RESUMEN
Acute lymphoblastic leukemia (ALL) is a malignant clonal expansion of lymphoid hematopoietic precursors that exhibit developmental arrest at varying stages of differentiation. Similar to what occurs in solid cancers, transformation of normal hematopoietic precursors is governed by a multistep oncogenic process that drives initiation, clonal expansion and metastasis. In this process, alterations in genes encoding proteins that govern processes such as cell proliferation, differentiation, and growth provide us with some of the clearest mechanistic insights into how and why cancer arises. In such a scenario, deletions in the 9p21.3 cluster involving CDKN2A/ARF/CDKN2B genes arise as one of the oncogenic hallmarks of ALL. Deletions in this region are the most frequent structural alteration in T-cell acute lymphoblastic leukemia (T-ALL) and account for roughly 30% of copy number alterations found in B-cell-precursor acute lymphoblastic leukemia (BCP-ALL). Here, we review the literature concerning the involvement of the CDKN2A/B genes as a prognosis marker of good or bad response in the two ALL subtypes (BCP-ALL and T-ALL). We compare frequencies observed in studies performed on several ALL cohorts (adult and child), which mainly consider genetic data produced by genomic techniques. We also summarize what we have learned from mouse models designed to evaluate the functional involvement of the gene cluster in ALL development and in relapse/resistance to treatment. Finally, we examine the range of possibilities for targeting the abnormal function of the protein-coding genes of this cluster and their potential to act as anti-leukemic agents in patients.
Asunto(s)
Biomarcadores de Tumor/genética , Cromosomas Humanos Par 9/genética , Familia de Multigenes , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Yin-Yang , Animales , Deleción Cromosómica , Inhibidor p15 de las Quinasas Dependientes de la Ciclina/genética , Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética , Modelos Animales de Enfermedad , Humanos , Proteína p14ARF Supresora de Tumor/genéticaRESUMEN
Vitamin C (VC) and vitamin D (VD) have been widely used as the dietary supplements and in treatment of diseases both independently and in combination. Whether there is a connection between their pathways is critical for their therapeutic applications. Using whole-genome expression profiles, we performed multiple measures of associations, networks, eQTL mappings and expressions of key genes of interest in VC and VD functions. Several key genes in their pathways were found to be associated. Gc and Rgn play important roles connecting VC and VD pathways in mice. The r values of expression levels between Gc and Rgn in mouse spleen, liver, lung, and kidney are 0.937, 0.558, 0.901, and 0.617, respectively. The expression QTLs of Gc and Rgn are mapped onto the same locations, i.e., 68-76 MB in chromosome 7 and 26-36 MB in chromosome 9. In humans, there are positive correlations between CYP27B1 and SLC23A1 expression levels in kidney (r = 0.733) and spleen (r = 0.424). SLC23A2 and RXRA are minimally associated in both mouse and human. These data indicate that pathways of VC and VD are not independent but affect each other, and this effect is different between mice and humans during VC and VD synthesis and transportation.
Asunto(s)
Ácido Ascórbico/metabolismo , Secuenciación del Exoma/métodos , Perfilación de la Expresión Génica/métodos , Redes Reguladoras de Genes , Sitios de Carácter Cuantitativo , Vitamina D/metabolismo , Animales , Transporte Biológico , Proteínas de Unión al Calcio/genética , Mapeo Cromosómico , Cromosomas Humanos Par 7/genética , Cromosomas Humanos Par 9/genética , Regulación de la Expresión Génica , Humanos , Péptidos y Proteínas de Señalización Intracelular/genética , Riñón/química , Hígado/química , Pulmón/química , Ratones , Especificidad de Órganos , Bazo/química , Proteína de Unión a Vitamina D/genéticaRESUMEN
BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Acute myeloid leukemia or myelodysplastic syndrome during the course of ALL is a rare entity. Some of these cases are therapy-related while the others occur due to lineage switch. The correct diagnosis relies on comparing the immunophenotypes and cytogenetic/molecular alterations of the myeloid neoplasm and the ALL. We present the clinical, pathologic and cytogenetic features of a case of an 18-year-old male with prior treatment for B-lymphoblastic leukemia (B-ALL) who developed therapy-related myeloid neoplasm (t-MN) 4-5years after his initial diagnosis of B-ALL. CASE PRESENTATION: A 13-year-old boy with no significant past medical history presented to Harbor-UCLA Medical Center (HUMC) in November 2012 with night sweats, fevers and chills, nausea, vomiting, diarrhea, fatigue, weakness, and weight loss. Peripheral blood flow cytometric analysis disclosed B-ALL. The blasts expressed CD10, CD19, CD22 (dim), CD34, CD38, HLA-DR, and TdT, and were negative for CD20, CD13, CD33, CD117, and cytoplasmic MPO. Chromosomal analysis and a supplemental fluorescence in situ hybridization (FISH) study performed on the bone marrow aspirate showed an abnormal karyotype (47,XY,+X,del(9)(p21p21)[4]/46,XY[16]). He achieved remission after induction chemotherapy and remained in remission until March 2016 when bilateral testicular masses were noted. Biopsy of the left testicular mass showed relapsed B-ALL. Cerebrospinal fluid (CSF) contained rare TdT-positive blasts, suggestive of minimal/early involvement by B-ALL. However, there was no evidence of acute leukemia in his bone marrow at this time. He was then treated with COG protocol AALL1331 randomized to blinatumomab arm and achieved second remission. In June 2017, the patient's peripheral blood smear showed 11% circulating monoblasts. By flow cytometry, the blasts expressed CD4, CD11b, CD13, CD15, CD33, CD38, CD56, and CD64. In addition, a few TdT-positive blasts were seen in his CSF cytospin smear. Bone marrow biopsy was subsequently performed which was consistent with evolving acute myeloid leukemia. A diagnosis of myeloid neoplasm, consistent with t-MN was made. Chromosomal analysis and FISH studies performed on his bone marrow aspirate showed normal karyotype (46,XY[20]), negative FISH result for deletion 9p21 locus, and positive KMT2A (MLL) rearrangement, respectively. Despite of chemotherapy, the patient died within one month after diagnosis. DISCUSSION AND CONCLUSION: Diagnosis of t-MN should be suspected in patients with a history of receiving cytotoxic agents and/or irradiation. In this case study, we diagnosed t-MN with KMT2A rearrangement in a patient with history of B-ALL with 9p deletion and gain of X chromosome. Unusual features associated with this case are discussed.
Asunto(s)
N-Metiltransferasa de Histona-Lisina/genética , Leucemia Mieloide Aguda/genética , Proteína de la Leucemia Mieloide-Linfoide/genética , Neoplasias Primarias Secundarias/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Adolescente , Cromosomas Humanos Par 9/genética , Cromosomas Humanos X/genética , Regulación Leucémica de la Expresión Génica , Humanos , Hibridación Fluorescente in Situ , Quimioterapia de Inducción/efectos adversos , Leucemia Mieloide Aguda/inducido químicamente , Leucemia Mieloide Aguda/diagnóstico , Leucemia Mieloide Aguda/patología , Masculino , Proteínas de Neoplasias/genética , Neoplasias Primarias Secundarias/inducido químicamente , Neoplasias Primarias Secundarias/diagnóstico , Neoplasias Primarias Secundarias/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologíaRESUMEN
Whole-genome sequencing (WGS) allows for a comprehensive view of the sequence of the human genome. We present and apply integrated methodologic steps for interrogating WGS data to characterize the genetic architecture of 10 heart- and blood-related traits in a sample of 1,860 African Americans. In order to evaluate the contribution of regulatory and non-protein coding regions of the genome, we conducted aggregate tests of rare variation across the entire genomic landscape using a sliding window, complemented by an annotation-based assessment of the genome using predefined regulatory elements and within the first intron of all genes. These tests were performed treating all variants equally as well as with individual variants weighted by a measure of predicted functional consequence. Significant findings were assessed in 1,705 individuals of European ancestry. After these steps, we identified and replicated components of the genomic landscape significantly associated with heart- and blood-related traits. For two traits, lipoprotein(a) levels and neutrophil count, aggregate tests of low-frequency and rare variation were significantly associated across multiple motifs. For a third trait, cardiac troponin T, investigation of regulatory domains identified a locus on chromosome 9. These practical approaches for WGS analysis led to the identification of informative genomic regions and also showed that defined non-coding regions, such as first introns of genes and regulatory domains, are associated with important risk factor phenotypes. This study illustrates the tractable nature of WGS data and outlines an approach for characterizing the genetic architecture of complex traits.
Asunto(s)
Negro o Afroamericano/genética , Estudio de Asociación del Genoma Completo , Lipoproteína(a)/genética , Troponina T/genética , Proteína C-Reactiva/metabolismo , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Cromosomas Humanos Par 9/genética , Frecuencia de los Genes , Genoma Humano , Genómica , Hemoglobinas/metabolismo , Humanos , Intrones , Recuento de Leucocitos , Lipoproteína(a)/sangre , Magnesio/sangre , Péptido Natriurético Encefálico/sangre , Péptido Natriurético Encefálico/genética , Neutrófilos/citología , Fragmentos de Péptidos/sangre , Fragmentos de Péptidos/genética , Fósforo/sangre , Recuento de Plaquetas , Polimorfismo de Nucleótido Simple , Sitios de Carácter Cuantitativo , Troponina T/sangre , Población Blanca/genéticaRESUMEN
Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity. We previously conducted a genome-wide association study (GWAS) and detected two loci associated with AIS. To identify additional loci, we extended our GWAS by increasing the number of cohorts (2,109 affected subjects and 11,140 control subjects in total) and conducting a whole-genome imputation. Through the extended GWAS and replication studies using independent Japanese and Chinese populations, we identified a susceptibility locus on chromosome 9p22.2 (p = 2.46 × 10(-13); odds ratio = 1.21). The most significantly associated SNPs were in intron 3 of BNC2, which encodes a zinc finger transcription factor, basonuclin-2. Expression quantitative trait loci data suggested that the associated SNPs have the potential to regulate the BNC2 transcriptional activity and that the susceptibility alleles increase BNC2 expression. We identified a functional SNP, rs10738445 in BNC2, whose susceptibility allele showed both higher binding to a transcription factor, YY1 (yin and yang 1), and higher BNC2 enhancer activity than the non-susceptibility allele. BNC2 overexpression produced body curvature in developing zebrafish in a gene-dosage-dependent manner. Our results suggest that increased BNC2 expression is implicated in the etiology of AIS.
Asunto(s)
Cromosomas Humanos Par 9/genética , Proteínas de Unión al ADN/genética , Predisposición Genética a la Enfermedad , Fenotipo , Polimorfismo de Nucleótido Simple/genética , Escoliosis/genética , Adolescente , Animales , China , Proteínas de Unión al ADN/metabolismo , Embrión no Mamífero/metabolismo , Embrión no Mamífero/patología , Estudio de Asociación del Genoma Completo , Humanos , Japón , Luciferasas , Oportunidad Relativa , Escoliosis/patología , Factor de Transcripción YY1/metabolismo , Pez CebraRESUMEN
BACKGROUND AND AIMS: Recent gene-environment interaction studies suggest that diet may influence an individual's genetic predisposition to cardiovascular risk. We evaluated whether omega-3 fatty acid intake may influence the risk for acute coronary syndrome (ACS) conferred by genetic polymorphisms among patients with early onset ACS. METHODS AND RESULTS: Our population consisted of 705 patients of white European descent enrolled in GENESIS-PRAXY, a multicenter cohort study of patients aged 18-55 years and hospitalized with ACS. We used a case-only design to investigate interactions between the omega-3 index (a validated biomarker of omega-3 fatty acid intake) and 30 single nucleotide polymorphisms (SNPs) robustly associated with ACS. We used logistic regression to assess the interaction between each SNP and the omega-3 index. Interaction was also assessed between the omega-3 index and a genetic risk score generated from the 30 SNPs. All models were adjusted for age and sex. An interaction for increased ACS risk was found between carriers of the chromosome 9p21 variant rs4977574 and low omega-3 index (OR 1.57, 95% CI 1.07-2.32, p = 0.02), but this was not significant after correction for multiple testing. Similar results were obtained in the adjusted model (OR 1.55, 95% CI 1.05-2.29, p = 0.03). We did not observe any interaction between the genetic risk score or any of the other SNPs and the omega-3 index. CONCLUSION: Our results suggest that omega-3 fatty acid intake may modify the genetic risk conferred by chromosome 9p21 variation in the development of early onset ACS and requires independent replication.
Asunto(s)
Síndrome Coronario Agudo/genética , Ácidos Grasos Omega-3/administración & dosificación , Predisposición Genética a la Enfermedad , Polimorfismo de Nucleótido Simple , Síndrome Coronario Agudo/epidemiología , Adolescente , Adulto , Biomarcadores/sangre , Cromosomas Humanos Par 9/genética , Estudios de Cohortes , Femenino , Interacción Gen-Ambiente , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Reproducibilidad de los Resultados , Factores de Riesgo , Adulto JovenRESUMEN
Primary muscle coenzyme Q10 (CoQ10) deficiency is an apparently autosomal recessive condition with heterogeneous clinical presentations. Patients with these disorders improve with CoQ10 supplementation. In a family with ataxia and CoQ10 deficiency, analysis of genome-wide microsatellite markers suggested linkage of the disease to chromosome 9p13 and led to identification of an aprataxin gene (APTX) mutation that causes ataxia oculomotor apraxia (AOA1 [MIM606350]). The authors' observations indicate that CoQ10 deficiency may contribute to the pathogenesis of AOA1.
Asunto(s)
Proteínas de Unión al ADN/genética , Hipoalbuminemia/genética , Proteínas Nucleares/genética , Degeneraciones Espinocerebelosas/genética , Ubiquinona/deficiencia , Sustitución de Aminoácidos , Preescolar , Cromosomas Humanos Par 9/genética , Análisis Mutacional de ADN , Proteínas de Unión al ADN/deficiencia , Proteínas de Unión al ADN/fisiología , Exones/genética , Femenino , Genes Recesivos , Humanos , Hiperlipoproteinemia Tipo II/genética , Lactante , Escala de Lod , Masculino , Debilidad Muscular/genética , Músculo Esquelético/química , Músculo Esquelético/patología , Mutación Missense , Proteínas Nucleares/deficiencia , Proteínas Nucleares/fisiología , Fenotipo , Mutación Puntual , Degeneraciones Espinocerebelosas/tratamiento farmacológico , Ubiquinona/uso terapéuticoRESUMEN
The recruitment and proliferation of smooth muscle cells and pericytes are two key events for the stabilization of newly formed capillaries during angiogenesis and, when out of control in the adult, are the main causes of arteriosclerosis. We have identified a novel gene, named VE-statin for vascular endothelial-statin, which is expressed specifically by endothelial cells of the developing mouse embryo and in the adult, and in early endothelial progenitors. The mouse and human VE-statin genes have been located on chromosome 2 and 9, respectively, they span >10 kbp and are transcribed in two major variants arising from independent initiation sites. The VE-statin transcripts code for a unique protein of 30 kDa that contains a signal peptide and two epidermal growth factor (EGF)-like modules. VE-statin is found in the cellular endoplasmic reticulum and secreted in the cell supernatant. Secreted VE-statin inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration, but has no effects on endothelial cell migration. VE-statin is the first identified inhibitor of mural cell migration specifically produced by endothelial cells.
Asunto(s)
Factores de Crecimiento Endotelial/fisiología , Endotelio Vascular/fisiología , Inhibidores de Crecimiento/fisiología , Músculo Liso Vascular/citología , Proteínas/fisiología , Factores de Transcripción/fisiología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteínas de Unión al Calcio , División Celular , Línea Celular , Movimiento Celular , Células Cultivadas , Cromosomas Humanos Par 9/genética , Clonación Molecular , ADN Complementario/genética , Proteínas de Unión al ADN , Familia de Proteínas EGF , Factores de Crecimiento Endotelial/genética , Endotelio Vascular/crecimiento & desarrollo , Inhibidores de Crecimiento/genética , Humanos , Hibridación Fluorescente in Situ , Técnicas In Vitro , Factores de Transcripción de Tipo Kruppel , Ratones , Datos de Secuencia Molecular , Músculo Liso Vascular/crecimiento & desarrollo , Músculo Liso Vascular/fisiología , Neovascularización Fisiológica , Proteínas/genética , Factores de Transcripción/genéticaRESUMEN
Phosphatidic acid (PA) is a component of cellular membranes that is also a mediator of certain cell signalling functions associated with oncogenesis. These include ras/raf/Erk and Akt/mTor [1-3]. The authors have investigated whether it would be possible to interrupt these known oncogenic pathways through the inhibition of lysophosphatidic acid acyltransferase (LPAAT), an enzyme that catalyses the biosynthesis of PA. The expression and activity of the LPAAT-beta isoform are elevated in human tumours, and the respective gene displays transforming capacity when overexpressed in vitro. Inhibition by either genetic means or by isoform-specific small molecules results in a block to cell signalling pathways and apoptosis. Furthermore, the small-molecule inhibitors of LPAAT-beta are not cytotoxic to a number of normal cell types, including primary bone marrow progenitors, indicating a differential dependence of tumour cells on LPAAT-beta function. These discoveries indicate that LPAAT-beta represents a potential novel cancer therapy target.
Asunto(s)
Aciltransferasas/antagonistas & inhibidores , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Diseño de Fármacos , Neoplasias/tratamiento farmacológico , Acilación/efectos de los fármacos , Aciltransferasas/genética , Aciltransferasas/fisiología , Animales , Antineoplásicos/uso terapéutico , Carcinoma Pulmonar de Lewis/tratamiento farmacológico , División Celular/efectos de los fármacos , División Celular/fisiología , Línea Celular Tumoral/efectos de los fármacos , Transformación Celular Neoplásica , Cromosomas Humanos Par 9/genética , Evaluación Preclínica de Medicamentos , Genes ras , Humanos , Hidrocarburos Halogenados/farmacología , Hidrocarburos Halogenados/uso terapéutico , Neoplasias Pulmonares/tratamiento farmacológico , Ratones , Proteínas de Neoplasias/antagonistas & inhibidores , Proteínas de Neoplasias/fisiología , Neoplasias/patología , Ácidos Fosfatidicos/fisiología , Conformación Proteica , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Triazinas/farmacología , Triazinas/uso terapéuticoRESUMEN
PURPOSE OF REVIEW: Dystonia is a movement disorder with a complex and not fully understood pathophysiology. Its better understanding would enable more focused treatment for the disorder. In this review, we provide an overview of recent studies of the pathophysiology of primary and secondary dystonia, with an emphasis on functional brain imaging. Potential mechanisms underlying the beneficial effects of deep brain stimulation for dystonia are also summarized. RECENT FINDINGS: The recognition of dysfunction at different levels of the nervous system has extended the classical notions of localized striatal abnormalities in primary dystonia. Recent biochemical studies have revealed evidence of abnormal torsion activity in DYT1 dystonia. Abnormal patterns of brain metabolism have also been identified using functional brain imaging in different dystonia genotypes. These findings, in conjunction with new electrophysiological techniques, can be utilized to help define a common mechanism for the neural dysfunction in dystonia. SUMMARY: New insights into the pathophysiology of dystonia have been provided by recent studies using electrophysiology, biochemistry and human genetics, as well as functional brain imaging studies. These advances together may create the basis for new therapies for this disorder.
Asunto(s)
Distonía/fisiopatología , Chaperonas Moleculares , Ganglios Basales/fisiopatología , Proteínas Portadoras/genética , Cromosomas Humanos Par 9/genética , Distonía/genética , Distonía/terapia , Terapia por Estimulación Eléctrica/instrumentación , Terapia por Estimulación Eléctrica/métodos , Humanos , Corteza Motora/fisiopatología , Inhibición Neural/fisiología , Mutación Puntual/genética , Receptores Presinapticos/fisiología , Corteza Somatosensorial/fisiopatología , Médula Espinal/fisiopatología , Tálamo/fisiopatologíaRESUMEN
Our 10-year translational study of the oral premalignant lesion (OPL) model has advanced the basic understanding of carcinogenesis. Although retinoids have established activity in this model, a substantial percentage of our OPL patients progress to cancer, especially after treatment is stopped. On the basis of our 10-year OPL study, we have developed the first comprehensive tool for assessing cancer risk of OPL patients. This cancer risk assessment tool incorporates medical/demographic variables, epidemiological factors, and cellular and molecular biomarkers. Between 1988 and 1991, 70 advanced OPL patients were enrolled in a chemoprevention trial of induction with high dose isotretinoin (1.5 mg/kg/day for 3 months) followed by 9 months of maintenance treatment with either low dose isotretinoin (0.5 mg/kg/day) or beta-carotene (30 mg/d; total treatment duration, 1 year). We assessed the relationship between cancer risk factors and time to cancer development by means of exploratory data analysis, logrank test, Cox proportional hazard model, and recursive partitioning. With a median follow-up of 7 years, 22 of our 70 patients (31.4%) developed cancers in the upper aerodigestive tract following treatment. The overall cancer incidence was 5.7% per year. The most predictive factors of cancer risk are OPL histology, cancer history, and three of the five biomarkers we assessed (chromosomal polysomy, p53 protein expression, and loss of heterozygosity at chromosome 3p or 9p). In the multivariable Cox model, histology (P = 0.0003) and the combined biomarker score of chromosomal polysomy, p53, and loss of heterozygosity (P = 0.0008) are the strongest predictors for cancer development. Retinoic acid receptor beta and micronuclei were not associated with increased cancer risk. We have demonstrated a successful strategy of comprehensive cancer risk assessment in OPL patients. Combining conventional medical/demographic variables and a panel of three biomarkers can identify high risk patients in our sample. This result will need to be validated by future studies. With the identification of high risk individuals, more efficient chemoprevention trials and molecular targeting studies can be designed.
Asunto(s)
Leucoplasia Bucal/complicaciones , Neoplasias de la Boca/etiología , Consumo de Bebidas Alcohólicas , Aberraciones Cromosómicas , Cromosomas Humanos Par 3/genética , Cromosomas Humanos Par 9/genética , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Isotretinoína/uso terapéutico , Leucoplasia Bucal/tratamiento farmacológico , Leucoplasia Bucal/patología , Pérdida de Heterocigocidad , Masculino , Persona de Mediana Edad , Boca/patología , Neoplasias de la Boca/patología , Análisis Multivariante , Valor Predictivo de las Pruebas , Pronóstico , Modelos de Riesgos Proporcionales , Ensayos Clínicos Controlados Aleatorios como Asunto , Receptores de Ácido Retinoico/metabolismo , Factores de Riesgo , Fumar , Proteína p53 Supresora de Tumor/metabolismoRESUMEN
A 3-kb-long cDNA encoding a Krüppel-like human zinc finger protein was isolated and mapped to chromosome 9q22-q31. The ZNF189 gene encodes a protein with 16 zinc fingers at its C-terminus and belongs to the Krüppel-associated box (KRAB)-containing group of zinc finger proteins. Four differently spliced cDNA transcripts, differing at the 5' coding region where a KRAB A repressor domain is encoded, were isolated. In addition, Northern blot analysis indicates the presence of two additional unidentified splice variants. Comparison of cDNA and genomic sequences shows that the ZNF189 gene spans approximately 11 kb and is organized into at least four exons, the large 3'-end exon coding for the complete zinc finger domain and the 3' untranslated region. ZNF189 is expressed in all tissues and cell types currently investigated, at varying levels, but with a tissue- or cell-type-restricted expression pattern for the different splice variants. ZNF189 is conserved in the genome of several mammalian species. Direct sequencing of the ZNF189 gene in microdissected tumor biopsies of sporadic basal cell carcinoma and squamous cell carcinoma reveals no mutations in the coding sequence or at exon/intron boundaries.
Asunto(s)
Cromosomas Humanos Par 9/genética , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Proteínas Represoras , Dedos de Zinc/genética , Secuencia de Aminoácidos , Secuencia de Bases , Northern Blotting , Carcinoma Basocelular/genética , Carcinoma de Células Escamosas/genética , Línea Celular , Mapeo Cromosómico , Clonación Molecular , ADN Complementario , ADN de Neoplasias/análisis , Exones/genética , Expresión Génica , Humanos , Hibridación Fluorescente in Situ , Intrones/genética , Factores de Transcripción de Tipo Kruppel , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Empalme del ARN , Análisis de Secuencia de ADN , Neoplasias Cutáneas/genética , Factores de Transcripción/química , Factores de Transcripción/genética , Células Tumorales CultivadasRESUMEN
Gorlin's syndrome or nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by a familial or hereditary predisposition to basal cell carcinomas (generally multiple and of early onset), odontogenic keratocysts (jaw cysts), palmar and plantar pits, a wide variety of developmental defects, as well as cancers such as medulloblastomas and ovarian fibromas. The gene for NBCCS has been mapped to human chromosome region 9q22.1-q31 by linkage analysis and by cytogenetic evidence of deletions in this region in patients with the syndrome. This is supported by loss of heterozygosity in tumors of polymorphic marker loci flanked by D9S197 and D9S180. We have utilized sequence tagged site (STS) mapping and somatic cell hybrid panel analysis to construct two overlapping yeast artificial chromosome (YAC) contigs spanning this region of the genome. We used the YAC contigs to identify a new zinc finger gene containing a highly informative microsatellite locus.
Asunto(s)
Síndrome del Nevo Basocelular/genética , Cromosomas Artificiales de Levadura/genética , Cromosomas Humanos Par 9/genética , Proteínas de Unión al ADN/genética , Proteínas Represoras , Factores de Transcripción/genética , Dedos de Zinc/genética , Secuencia de Aminoácidos , Secuencia de Bases , Mapeo Cromosómico , Cósmidos , Islas de CpG , ADN Complementario , Eliminación de Gen , Biblioteca Genómica , Heterocigoto , Humanos , Factores de Transcripción de Tipo Kruppel , Repeticiones de Microsatélite , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN , Lugares Marcados de SecuenciaRESUMEN
trk (NTRK) genes encode tyrosine kinase transmembrane receptors that are stimulated by neurotrophins, and are responsible for the transduction of signals controlling neuropoiesis and neuron survival in the central and peripheral nervous system, trkA gene has earlier been assigned to three different loci on chromosome 1. To resolve these conflicting results, and confirm the localization of trkB and trkC, probes specific to each of these related genes were constructed and used in fluorescent in situ hybridization on human metaphase cells. Our results indicate that trkA, trkB and trkC are located in chromosome bands 1q22, 9q22 and 15q25, respectively.